Combined Oral Contraceptives with 30-35 μg Ethinyl Estradiol
For a 12-year-old with heavy menstrual bleeding, prescribe a monophasic combined oral contraceptive containing 30-35 μg of ethinyl estradiol with levonorgestrel or norgestimate as first-line therapy. 1
Recommended Formulations
- Monophasic pills containing 30-35 μg ethinyl estradiol plus levonorgestrel or norgestimate are the preferred initial therapy for adolescents with menorrhagia 1
- These formulations decrease menstrual blood loss and cramping by inducing regular shedding of a thinner endometrium 1
- The higher estrogen dose (30-35 μg) is specifically recommended over lower doses (20 μg) for treating heavy bleeding in this population 1
Mechanism and Efficacy
- Combined oral contraceptives improve treatment success dramatically—if only 3% of adolescents respond to placebo, COCs increase this to 12-77% 2
- COCs reduce menstrual blood loss by 20-60% through endometrial thinning and ovulation inhibition 3, 2
- The medication works by inducing regular shedding of a thinner endometrium while providing contraceptive protection 4, 1
Initiation and Timing
- Start the pill at any time if reasonably certain the patient is not pregnant 4
- If started within the first 5 days of menstrual bleeding, no backup contraception is needed 4
- If started >5 days after bleeding began, use backup contraception (condoms) for 7 consecutive days 4
Extended Regimen Considerations
For severe bleeding or anemia, consider an extended regimen where the patient takes active pills continuously for 3-4 months, followed by a 4-7 day hormone-free interval 1
Managing breakthrough bleeding with extended regimens:
- Do not allow a hormone-free interval during the first 21 days of continuous use 1
- If breakthrough bleeding occurs after 21 days, a 3-4 day hormone-free interval can be taken, but not more than once per month 1
- NSAIDs for 5-7 days can help manage persistent bleeding 4, 1
Additional Benefits Beyond Bleeding Control
- Improvement in acne 1
- Reduced risk of endometrial and ovarian cancers with long-term use 1
- Does not increase risk of infertility or breast cancer 1
- Provides effective contraception if the adolescent becomes sexually active 4, 1
Safety Profile in Adolescents
- Smoking is NOT a contraindication in patients under 35 years old 1
- Common transient side effects include irregular bleeding (especially first 3-6 months), headache, nausea, and breast pain 1
- COCs increase venous thromboembolism risk 3-4 fold, but absolute risk remains low (4 per 10,000 woman-years) 1
Critical Counseling Points
- Emphasize consistent condom use for STI protection regardless of contraceptive method, as all sexually active adolescents should use condoms 1
- Ensure confidential discussion, as adolescents are significantly less likely to use family planning services without confidentiality assurances 1
- Teach what to do if pills are missed: take the most recently missed pill immediately, and remember that 7 consecutive hormone pills are needed to prevent ovulation 1
- Use adherence strategies like cell phone alarms or family member support 1
Monitoring Requirements
- No routine follow-up visit is required 4, 1
- Advise the patient to return for side effects, concerns, or desire to change methods 4, 1
- Monitor blood pressure at follow-up visits 4, 1
- Assess satisfaction with the method and any health status changes 4
When to Evaluate Further
Before treating breakthrough bleeding, rule out:
- Pregnancy 1
- Sexually transmitted infections 1
- Thyroid disorders 1
- New pathologic uterine conditions (polyps or fibroids) 1
- Medication interactions 1